Vitamin E in onoxaliplatin-induced neuropathy prevention
Ontology highlight
ABSTRACT: Intervention 1: in intervention group :vitamin E 400 mg daily. Intervention 2: Control group were observed.;Prevention;in intervention group :vitamin E 400 mg daily;Control group were observed
Primary outcome(s): Peripheral neuropathy. Timepoint: before study and then 3 months later. Method of measurement: questionnaire.
Study Design: Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.
DISEASE(S): Drug-induced Polyneuropathy,Malignant Neoplasm Of Rectosigmoid Junction,Condition 1: Cancer Of Colorectal. Condition 2: Pripheral Neuropathy
PROVIDER: 2485714 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA